Sunny Pharmtech Inc.

NT$6.98As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6676Healthcare
Country Taiwan
PE (Fwd) •••
TSR 5Y CAGR (21.78%)
Div yield —
ROE (37.94%)
Biotechnology
Beta (5Y) 0.37
PE TTM —
TSR TTM (51.70%)
Mkt cap NT$1.184B
ROIC (17.61%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$7.42
6.34%
(20.12%)
Hold 7|1|4|10|11
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.12
0.12
0.13
0.13
9.01%
2.55%
4.64%
5.11%
RevenueNT$M
72.15
71.87
72.37
76.11
5.42%
1.41%
3.47%
3.68%
Peers (US$36.28M)
Cap (US$)
PE
37.25M
—
35.75M
26.42x
36.15M
—
Capital
TTM
5Y
10Y
Leveragex
0.116
(0.100)
(0.102)
EBIT/Intx
0.783
0.195
0.190
Own earn%
(13.40)
(119.94)
(101.63)
Sh yield%
29.93
38.47
36.25
Owners
Insiders/Inst%
1.09
77.87
Short interest%
5.91
SBC / revenue%
0.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
26–31
$1 testx
−0.3
Incr. ROIC%
−1